To delineate a potential mechanism of CEACAM-1 blockade for anti-tumor therapy, the expression profile of surface CEACAM-1 in tumor infiltrates was comprehensively assessed using flow cytometry. The gene discussed is CEACAM1; the disease is neoplasm.